Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 70518-2259

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 70518-2259). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Venlafaxine HCI extended-release capsules in 150mg strength. This package contains 90 capsules with NDC number 70518-2259-00 and an expiration date, but no LOT number. The source NDC number is 65862-0697-90 and the manufacturer is Aurobindo Pharma. The medication should be kept out of reach of children and stored at temperatures between 20-26°C (63-77°F), with excursions permitted up to 15-30°C (59-86°F). For instructions on use, refer to the package insert. The medication has been repackaged by RemedyRepack Inc. in Indiana, PA.*
FDA Label Image

Venlafaxine HCl 150mg 70518 2259 01

Venlafaxine HCl 150mg 70518 2259 01
Venlafaxine HCI is an extended-release medication in the form of a 150mg capsule that comes in a quantity of 90. The medication is manufactured by Aurcbindo Pharma in Dayton, NJ, and is repackaged by RemedyRepack Inc. in Indiana, PA. The National Drug Code (NDC) is 70518-2259-01, and the source NDC is 65862-0697-05. There is no information on the expiry date or lot number provided. The medication should be stored at 20-26°C (63-77°F), with excursions permitted to 15-30°C (59-86°F) and kept out of the reach of children. Directions for use are available in the package insert.*
FDA Label Image

Venlafaxine HCl 150mg 70518 2259 02

Venlafaxine HCl 150mg 70518 2259 02
Venlafaxine HCI Extended-Release 150mg Capsules, packaged by RemedyRepack Inc., contain 30 capsules with an NDC number 70518-2259-02. This medication is manufactured by Aurcbindo Pharma and should be stored between 20-26°C (63-77°F), with excursions permitted to 15-30°C (59-86°F). The directions for use should be followed as stated in the package insert. No expiration date and lot number are provided in the text. Keep this medicine out of the reach of children.*
FDA Label Image

Venlafaxine HCl 150mg 70518 2259 03

Venlafaxine HCl 150mg 70518 2259 03
Venlafaxine HCI is a medication available in the form of extended-release capsules with a strength of 150 mg. The package contains 30 capsules with an NDC number of 70518-2259-03 and should be stored at a temperature between 20-26°C (63-77°F). The product has been repackaged by RemedyRepack Inc. in Indiana, PA, and its source NDC is 65862-0697-90. The capsule is manufactured by Aurcbindo Pharma in Dayton, NJ. The information does not specify the expiry date or lot number. The package insert should be referred to for directions on usage.*
FDA Label Image

Venlafaxine HCl 150mg 70518 2259 04

Venlafaxine HCl 150mg 70518 2259 04
Venlafaxine HCI is an extended-release medication in the form of 150 mg capsules. Each bottle contains 30 capsules and has an NDC number of 70518-2259-04. There is no specified expiration date or lot number. It is manufactured by Aurobindo Pharma and distributed by Source NDC 65862-0697-05. It is recommended to keep this medication out of the reach of children and to store it between 20-26°C (63-77°F) with permissible excursions from 15-30°C (59-86°F). This specific bottle has been repackaged by RemedyRepack Inc. in Indiana. The package insert should be referred to for directions on use.*
FDA Label Image

Figure 1: Effect Of Interacting Drugs On The Pharmacokinetics Of Venlafaxine And Active Metabolite O-desmethylvenlafaxine (odv). (Venlafaxine Fig1)

Figure 1: Effect Of Interacting Drugs On The Pharmacokinetics Of Venlafaxine And Active Metabolite O-desmethylvenlafaxine (odv). (Venlafaxine Fig1)
Description not available.*
FDA Label Image

Figure 2: Effect Of Venlafaxine On The Pharmacokinetics Interacting Drugs And Their Active Metabolites. (Venlafaxine Fig2)

FDA Label Image

Figure 3: Pharmacokinetics Of Venlafaxine And Its Metabolite O-desmethylvenlafaxine (odv) In Special Populations. (Venlafaxine Fig3)

FDA Label Image

Chemical Structure (Venlafaxine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.